Biomarkers

Predicting seizures in patients with dementia 1:18
Predicting seizures in patients with dementia
Ifrah Zawar • 2 Dec 2022
Predicting post-stroke epilepsy occurrence 4:17
Predicting post-stroke epilepsy occurrence
Carolina Ferreira-Atuesta • 15 Dec 2022
Brain MRI vs. spinal cord MRI in measuring cervical spinal cord atrophy 2:15
Brain MRI vs. spinal cord MRI in measuring cervical spinal cord atrophy
Burcu Zeydan • 27 Oct 2022
Differential diagnosis of MS patients using serum proteomics: disease state & MS subtype 2:13
Differential diagnosis of MS patients using serum proteomics: disease state & MS subtype
Ferhan Qureshi • 26 Oct 2022
Unmet needs in the diagnostics and treatment of NMOSD 3:00
Unmet needs in the diagnostics and treatment of NMOSD
Kazuo Fujihara • 28 Oct 2022
The association between serum/CSF biomarkers and OCT measures in CIS patients 2:05
The association between serum/CSF biomarkers and OCT measures in CIS patients
Angela Vidal-Jordana • 26 Oct 2022
OCT measures association with serum/CSF biomarkers in CIS patients 2:00
OCT measures association with serum/CSF biomarkers in CIS patients
Jaume Sastre-Garriga • 28 Oct 2022
Biomarkers of disease activity and treatment response in MS 3:10
Biomarkers of disease activity and treatment response in MS
Mar Tintoré • 4 Nov 2022
Relationship between UCC atrophy and brain metrics of disease activity in MS 1:35
Relationship between UCC atrophy and brain metrics of disease activity in MS
Burcu Zeydan • 27 Oct 2022
MDSA test classifies relapsing MS patients based on steroid response and disease activity status 1:04
MDSA test classifies relapsing MS patients based on steroid response and disease activity status
Ferhan Qureshi • 26 Oct 2022
Blood serum proteome correlates of MS disease progression: a 5-year longitudinal study 1:38
Blood serum proteome correlates of MS disease progression: a 5-year longitudinal study
Ferhan Qureshi • 26 Oct 2022
Validation of the MSDA test in plasma 1:18
Validation of the MSDA test in plasma
Ferhan Qureshi • 26 Oct 2022
Biomarkers in small vessel disease 1:48
Biomarkers in small vessel disease
Hsin-Hsi Tsai • 31 Oct 2022
Cerebral microbleeds and cognitive decline 2:07
Cerebral microbleeds and cognitive decline
Hsin-Hsi Tsai • 31 Oct 2022
Upcoming MRI biomarkers in multiple sclerosis 1:09
Upcoming MRI biomarkers in multiple sclerosis
Jaume Sastre-Garriga • 28 Oct 2022
Role of imaging biomarkers of myelin repair in the development of neuroprotective drugs 0:43
Role of imaging biomarkers of myelin repair in the development of neuroprotective drugs
Cristina Granziera • 28 Oct 2022
The content of VJNeurology is intended for healthcare professionals